The relationship between anthropometry and serum concentrations of alkaline phosphatase isoenzymes, liver enzymes, albumin, and bilirubin

American Journal of Clinical Pathology

Volumn 126, Issue 3, 2006, Pages 437-442

  Ali, Aus T ^a   Paiker, Janice E ^a   Crowther, Nigel J ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Abdominal obesity; Alanine aminotransferase; Alkaline phosphatase isoenzymes; Levamisole; Liver function

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; ISOENZYME; LIVER ENZYME; PROTEIN;

ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; CHRONIC DISEASE; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; LIFESTYLE; MEMBRANE BINDING; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; TISSUE DISTRIBUTION;

EID: 33748342952     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/9N346GXX67B6PX5W     Document Type: Article

References (35)

1. Bray GA. Risks of obesity. Endocrinol Metab Clin N Am. 2003;32:787-804.
2. Ali AT, Crowther NJ. The health consequences of obesity. J Endocrinol Metab Diabet S Afr. 2005;10:56-61.
3. Galambos JT, Wills CE. Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology. 1978;74:1191-1199.
4. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med. 1979;67:811-816.
5. Yu AS, Keeffe EB. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord. 2002;2:11-19.
6. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844-1850.
7. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest, 2004;114:147-152.
8. Marceau P, Biron S, Hould FS, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999;84:1513-1517.
9. Weiss MJ, Henthorm PS, Lafferty MA, et al. Isolation and characterization of cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proc Natl Acad Sci U S A. 1986;83:7182-7186.
10. Berger J, Garattni E, Hua J-C, et al. Cloning and sequencing of human intestinal alkaline phosphatase cDNA. Proc Natl Acad Sci U S A. 1987;84:695-698.
11. Millan JL. Oncodevelopmental expression and structure of alkaline phosphatase genes. Anticancer Res. 1988;8:995-1005.
12. Meyer-Sabellek W, Sinha P, Kottgen E. Alkaline phosphatase: laboratory and clinical implications. J Chromatogr. 1988;429:419-444.
13. Crofton P. Wheat germ affinity electrophoresis for alkaline phosphatase isoforms in children: age dependent reference ranges and changes in liver and bone disease. Clin Chem. 1992;38:663-670.
14. Price CP. Multiple forms of human serum alkaline phosphatase: detection and quantitation. Ann Clin Biochem. 1993;30:355-371.
15. Ali AT, Penny C, Paiker JE, et al. Alkaline phosphatase is involved in the control of adipogenesis in the murine preadipocyte cell line, 3T3-L1. Clin Chim Acta. 2005;354:101-109.
16. Ali AT, Penny CB, Paiker JE, et al. The effect of alkaline phosphatase inhibitors on intracellular lipid accumulation in preadipocytes isolated from human mammary tissue. Ann Clin Biochem. 2006;43(pt 3):207-213.
17. van Belle H. Alkaline phosphatase, 1: kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin Chem. 1978;22:972-976.
18. Barrett-Connor E. Epidemiology of the menopause: a global overview. Int J Fertil Menopausal Stud. 1993;38(suppl 1):6-14.
19. Schiele F, Henny J, Hitz J, et al. Total bone and liver alkaline phosphatase in plasma: biological variations and reference limits. Clin Chem. 1983;29:634-641.
20. Munan L, Kelly A, PetitClerc C, et al. Associations with body weight of selected chemical constituents in blood: epidemiologic data. Clin Chem. 1978;24:772-777.
21. Cortez-Pinto H, Camilo ME, Baptista A, et al. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr. 1999;18:353-358.
22. Hollmann M, Runnebaum B, Gerhard I. Impact of waist-hip-ratio and body-mass-index on hormonal and metabolic parameters in young, obese women. Int J Obes Relat Metab Disord. 1997;21:476-483.
23. Thulstrup AM, Norgard B, Steffensen FH, et al. Waist circumference and body mass index as predictors of elevated alanine transaminase in Danes aged 30 to 50 years. Dan Med Bull. 1999;46:429-431.
24. Crilly RG, Jones MM, Horsman A, et al. Rise in plasma alkaline phosphatase at the menopause. Clin Sci (Lond). 1980;58:341-342.
25. van Belle H, De Broe ME, Wieme RJ. L-p-Bromotetramisole, a new reagent for use in measuring placental or intestinal isoenzymes of alkaline phosphatase in human serum. Clin Chem. 1977;23:454-459.
26. Adeniyi FA, Olatunbosum DS. Origins and significance of the increased plasma alkaline phosphatase during normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol. 1984;91:857-862.
27. Warnock ML. Intestinal phosphatase and fat absorption. Proc Soc Exp Biol Med. 1968;129:768-771.
28. Day AP, Feher MD, Chopra R, et al. The effect of bezafibrate treatment on serum alkaline phosphatase isoenzyme activities. Metabolism. 1993;42:839-842.
29. Statland BE, Nishi HH, Young DS. Serum alkaline phosphatase: total activity and isoenzyme determinations made by use of the centrifugal fast analyzer. Clin Chem. 1972;18:1468-1474.
30. Shephard MD, Peake MJ, Walmsley RN. Quantitative method for determining serum alkaline phosphatase isoenzymes activity, II: development and clinical application of method for measuring four serum alkaline phosphatase isoenzymes. J Clin Pathol. 1986;39:1031-1038.
31. Hirano K, Matsumoto H, Tanaka T, et al. Specific assays for human alkaline phosphatase isozymes. Clin Chim Acta. 1987;166:265-273.
32. Parviainen MT, Galloway JH, Towers JH, et al. Alkaline phosphatase isoenzymes in serum determined by high-performance anion-exchange liquid chromatography with detection by enzyme reaction. Clin Chem. 1988;34:2406-2409.
33. Bailyes EM, Seymour PM, Fulton I, et al. A monoclonal antibody capture assay for intestinal alkaline phosphatase and the measurement of this isoenzyme in pregnancy. Clin Chim Acta. 1988;172:267-274.
34. Brown PB, Lewis KO. Reaction rate retardation as a method for serum alkaline phosphatase serum isoenzyme measurement. Ann Clin Biochem. 1980;17:192-198.
35. Rosalki SB, Foo AY. Two new methods for measuring and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem. 1984;30:1182-1186.